Position in BBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$100,714,388
+$6,949,925 QoQ
Shares Held
1,352,234
+7.1% QoQ
Ownership
0.692%
of shares outstanding
% of Portfolio
7.63%
of 13F equity value
Holder Rank
#36
of 472 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names. BBIO ranks #1 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,352,234 | $100,714,388 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,506,152 | $67,615,980 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,820,013 | $44,417,673 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,002,701 | $15,260,581 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,900,888 | $14,751,672 | |
| 6 | IMUX |
Immunic, Inc.
|
610,326 | $9,380,710 | |
| 7 | AARD |
Aardvark Therapeutics, Inc.
|
1,034,459 | $5,958,483 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $5,306,601 |
All Filings in BBIO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,714,388 | 1,352,234 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $93,764,463 | 1,262,651 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $107,250,453 | 1,402,150 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $91,079,075 | 1,753,544 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $104,117,688 | 2,411,248 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $102,955,233 | 2,978,167 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $102,650,186 | 3,740,896 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $99,148,419 | 3,894,282 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $111,170,153 | 4,388,873 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $160,052,061 | 5,176,328 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $211,612,798 | 5,241,833 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $149,017,898 | 5,651,039 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $81,688,699 | 4,749,343 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $58,241,544 | 3,512,759 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,941,195 | 2,223,254 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,124,921 | 2,024,640 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,388,006 | 1,474,450 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,063,537 | 695,915 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||